Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study
暂无分享,去创建一个
M. Dougados | D. M. van der Heijde | P. Emery | S. de Bono | S. Beattie | M. Greenwald | I. de la Torre | Jiajun Liu | Ying-Chou Chen | Terence Rooney | E. Drescher | C. Gaich | D. Schlichting | S. Witt